VBL Therapeutics (Nasdaq: VBLT) 20% HIGHER; announced that principal investigator, Richard Penson, M.D., M.R.C.P., will present interim data from the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE